Genocea Biosciences (Genocea Biosciences) Total Assets : $38.79 Mil (As of Mar. 2022)

View and export this data going back to 2014. Start your Free Trial

What is Genocea Biosciences Total Assets?

Genocea Biosciences's Total Assets for the quarter that ended in Mar. 2022 was $38.79 Mil.

Total Assets is connected with ROA %. Genocea Biosciences's annualized ROA % for the quarter that ended in Mar. 2022 was -134.90%. Total Assets is also linked to Revenue through Asset Turnover. Genocea Biosciences's Asset Turnover for the quarter that ended in Mar. 2022 was 0.01.

Genocea Biosciences Total Assets Historical Data

The historical data trend for Genocea Biosciences's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genocea Biosciences Total Assets Chart

Genocea Biosciences Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Total Assets

Get a 7-Day Free Trial

17.49

31.12

52.61

98.49

55.97

Genocea Biosciences Quarterly Data
	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Total Assets	Get a 7-Day Free Trial															83.94	77.38	64.92	55.97	38.79

Genocea Biosciences Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Genocea Biosciences's Total Assets for the fiscal year that ended in Dec. 2021 is calculated as

Total Assets	=	Total Equity (A: Dec. 2021 )	+	Total Liabilities (A: Dec. 2021 )
	=	27.075	+	28.892
	=	55.97

Genocea Biosciences's Total Assets for the quarter that ended in Mar. 2022 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2022 )	+	Total Liabilities (Q: Mar. 2022 )
	=	12.385	+	26.403
	=	38.79

Genocea Biosciences (OTCPK:GNCAQ) Total Assets Explanation

Total Assets is connected with ROA %.

Genocea Biosciences's annualized ROA % for the quarter that ended in Mar. 2022 is

ROA %	=	Net Income (Q: Mar. 2022 )	/	( (Total Assets (Q: Dec. 2021 )	+	Total Assets (Q: Mar. 2022 ))	/ count )
	=	-63.912	/	( (55.967	+	38.788)	/ 2 )
	=	-63.912	/	47.3775
	=	-134.90 %

Note: The Net Income data used here is four times the quarterly (Mar. 2022) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Genocea Biosciences's Asset Turnover for the quarter that ended in Mar. 2022 is

	Asset Turnover
=	Revenue (Q: Mar. 2022 )	/	( (Total Assets (Q: Dec. 2021 )	+	Total Assets (Q: Mar. 2022 ))	/ count )
=	0.27	/	( (55.967	+	38.788)	/ 2 )
=	0.27	/	47.3775
=	0.01

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Genocea Biosciences Total Assets Related Terms

Thank you for viewing the detailed overview of Genocea Biosciences's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Genocea Biosciences (Genocea Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genocea Biosciences Inc (OTCPK:GNCAQ) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 Acorn Park Drive, Cambridge, MA, USA, 02140

Website

https://www.genocea.com

Genocea Biosciences Inc is a US-based biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies to address diseases with significant unmet needs. Its product candidate includes GEN-003 which is an immunotherapy for the treatment of genital herpes as well as it owns a pre-clinical immuno-oncology program focused on personalized cancer vaccines. The company focuses on developing vaccines and immunotherapies for unmet needs through its AnTigen Lead Acquisition System, which is used to design vaccines and immunotherapies. Genocea operates its business through the single segment being Developing and Commercializing vaccines.

Executives

Jacquelyn L Sumer	officer: CHIEF LEGAL & COMPLIANCE OFF	C/O GENOCEA BIOSCIENCES, INC., 100 ACORN PARK DRIVE 5TH FLOOR, CAMBRIDGE MA 02140
William D Clark	director, officer: President and CEO	C/O GENOCEA BIOSCIENCES, INC., 100 ACORN PARK DRIVE 5TH FLOOR, CAMBRIDGE MA 02140
George Siber	director	2000 BROADWAY, PENTHOUSE 2B, NEW YORK NY 10023
Diantha Duvall	officer: CHIEF FINANCIAL OFFICER	C/O GENOCEA BIOSCIENCES, INC., 100 ACORN PARK DRIVE 5TH FLOOR, CAMBRIDGE MA 02140
Scott D Sandell	10 percent owner
Stapleton Raymond D Jr	officer: EVP PHARM SCI & MFG	C/O GENOCEA BIOSCIENCES, INC., 100 ACORN PARK DRIVE 5TH FLOOR, CAMBRIDGE MA 02140
Jessica Baker Flechtner	officer: VP of Research	C/O GENOCEA BIOSCIENCES, INC., 100 ACORN PARK DRIVE, 5TH FLOOR, CAMBRIDGE MA 02140
Carmen Chang	10 percent owner	2855 SAND HILL ROAD, MENLO PARK CA 94025
New Enterprise Associates 16, L.p.	10 percent owner	1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Paul Edward Walker	10 percent owner	1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Mohamad Makhzoumi	10 percent owner	2855 SAND HILL ROAD, MENLO PARK CA 94025
Ali Behbahani	director	5425 WISCONSIN AVE, CHEVY CHASE MD 20815
Forest Baskett	10 percent owner
Peter W. Sonsini	10 percent owner	2855 SAND HILL ROAD, MENLO PARK CA 94025
Florence Anthony A. Jr.	10 percent owner	5425 WISCONSIN AVENUE, SUITE 800, CHEVY CHASE MD 20815